Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life.
Stefano
S
Palomba
Francesco
F
Orio
Tiziana
T
Russo
Angela
A
Falbo
Amato
A
Amati
Fulvio
F
Zullo
D000328:Adult; D000339:Affect; D000704:Analysis of Variance; D003071:Cognition; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D007558:Italy; D007889:Leiomyoma / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology*; D018579:Patient Selection; D010919:Placebos; D017697:Premenopause; D011788:Quality of Life; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D016037:Single-Blind Method; D012959:Socioeconomic Factors; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology*
D004965:Estrogen Antagonists; D010919:Placebos; D007987:Gonadotropin-Releasing Hormone; D020849:Raloxifene Hydrochloride